Written by Jen Finn
December 5, 2012
Salmon that's been genetically modified to grow twice as fast as normal could soon show up on your dinner plate. That is, if the company that makes the fish can stay afloat.
After weathering concerns about everything from the safety of humans eating the salmon to their impact on the environment, Aquabounty was poised to become the world's first company to sell fish whose DNA has been altered to speed up growth.
The Food and Drug Administration in 2010 concluded that Aquabounty's salmon was as safe to eat as the traditional variety. The agency also said that there's little chance that the salmon could escape and breed with wild fish, which could disrupt the fragile relationships between plants and animals in nature. But more than two years later the FDA has not approved the fish, and Aquabounty is running out of money.
"It's threatening our very survival," says CEO Ron Stotish, chief executive of the Maynard, Mass.-based company. "We only have enough money to survive until January 2013, so we have to raise more. But the unexplained delay has made raising money very difficult."
Read the full story at Mercury News>>
The Northeast Fisheries Science Center has announced that Dr. Jon Hare has been selected to serve as the permanent science and research director effective Oct. 31.Read more ...
It’s no secret that fraud is a problem in the seafood industry. Oceana repeatedly touts a mislabeling epidemic. While their method has been criticized, the perception of rampant fraud has been established.Read more ...